AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28177167 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study 25488965 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment at high-accruing centers (HHACs)
Number of subjects: 471
Study 25488965 — intervention group
Group type: COMPARATOR
Intervention: Treatment at historically low-accruing centers (HLACs)
Number of subjects: 471
Study 25488965 — intervention group
Group type: COMPARATOR
Intervention: Treatment at HLACs with radiotherapy compliance adjustment
Number of subjects: 471
Study 23963895 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 666
Study 23963895 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 666
Study 23963895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 666
Study 21318932 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated group prenatal care intervention (CenteringPregnancy Plus, CP+)
Number of subjects: 1047
Study 21318932 — intervention group
Group type: COMPARATOR
Intervention: Standard individual care
Number of subjects: 1047
Study 19583932 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese compound herbal medicine for reinforcing qi, activating blood circulation, expelling phlegm and dredging collaterals + simvastatin
Number of subjects: 60
Study 19583932 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 60
Study 17081270 — intervention group
Group type: EXPERIMENTAL
Intervention: Efalizumab (1.0 mg/kg/week for 12 weeks)
Number of subjects: 308
Study 17081270 — intervention group
Group type: EXPERIMENTAL
Intervention: Efalizumab re-treatment after relapse
Number of subjects: 308
Study 17081270 — intervention group
Group type: COMPARATOR
Intervention: Efalizumab (initial treatment)
Number of subjects: 308
Study 15646475 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% or greater pressure reduction
Number of subjects: 0
Study 15646475 — intervention group
Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 0
Study 15646475 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors (gender, ethnic background, migraine, disc hemorrhage)
Number of subjects: 0
Study 11705718 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychomotor processing speed
Number of subjects: 60
Study 11705718 — intervention group
Group type: EXPERIMENTAL
Intervention: Reaction time measures
Number of subjects: 60
Study 11705718 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT assessments
Number of subjects: 60
Study 9231452 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking and Driving Component
Number of subjects: 0
Study 9231452 — intervention group
Group type: COMPARATOR
Intervention: Comparison communities
Number of subjects: 0
Study 9231452 — intervention group
Group type: EXPERIMENTAL
Intervention: Responsible beverage service policies
Number of subjects: 0
Study 9231452 — intervention group
Group type: EXPERIMENTAL
Intervention: Local ordinances and regulations
Number of subjects: 0
Study 8180400 — intervention group
Group type: EXPERIMENTAL
Intervention: Filtered red blood cells and platelets
Number of subjects: 123
Study 8180400 — intervention group
Group type: COMPARATOR
Intervention: Standard red blood cells and platelets (nonfilter)
Number of subjects: 123
Study 31527020 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBDRplus group (discontinuation of ethambutol based on MTBDRplus assay results)
Number of subjects: 600
Study 31527020 — intervention group
Group type: COMPARATOR
Intervention: Guideline group (discontinuation of ethambutol based on phenotypic drug susceptibility test)
Number of subjects: 600
Study 31527020 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBDRplus group
Number of subjects: 600
Study 31527020 — intervention group
Group type: COMPARATOR
Intervention: Guideline group
Number of subjects: 600
Study 30222081 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine and cerium nitrate
Number of subjects: 50
Study 30222081 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 50
Study 27043785 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis (group A)
Number of subjects: 44
Study 27043785 — intervention group
Group type: COMPARATOR
Intervention: Control (group B)
Number of subjects: 44
Study 25381076 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse navigation (navigation)
Number of subjects: 147
Study 25381076 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 147
Study 22836050 — intervention group
Group type: EXPERIMENTAL
Intervention: 64 Gy in 32 fractions over 6.4 weeks RT schedule
Number of subjects: 34
Study 22836050 — intervention group
Group type: COMPARATOR
Intervention: 55 Gy in 20 fractions over 4 weeks RT schedule
Number of subjects: 34
Study 19916101 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic HD carriers
Number of subjects: 105
Study 19916101 — intervention group
Group type: COMPARATOR
Intervention: Noncarriers
Number of subjects: 105
Study 18383967 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevo-N2O group inhaled 8% sevoflurane in a 60/40% mixture of oxygen and N2O
Number of subjects: 44
Study 18383967 — intervention group
Group type: COMPARATOR
Intervention: Sevo-air group received 8% sevoflurane in a mixture of oxygen and air (inspired oxygen fraction, 40%)
Number of subjects: 44
Study 16323175 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice therapy
Number of subjects: 23
Study 16323175 — intervention group
Group type: COMPARATOR
Intervention: Control group (no voice therapy)
Number of subjects: 23
Study 12725761 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI (repetitive flexion-extension of the last four fingers of the right hand)
Number of subjects: 16
Study 12725761 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional MRI scans
Number of subjects: 16
Study 12725761 — intervention group
Group type: EXPERIMENTAL
Intervention: New, unlocalized proton MR spectroscopy (1HMRS) sequence to measure the concentration of N-acetylaspartate of the whole brain (WBNAA)
Number of subjects: 16
Study 11076818 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirofiban plus heparin
Number of subjects: 1570
Study 11076818 — intervention group
Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 1570
Study 8780451 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bed nets (ITBN)
Number of subjects: 0
Study 8780451 — intervention group
Group type: COMPARATOR
Intervention: Control infants
Number of subjects: 0
Study 1600930 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium (3 mg) added to meals containing iron (0.01 mg)
Number of subjects: 57
Study 1600930 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of milk, milkshake, or cheese to meals (pizza or hamburger)
Number of subjects: 57
Study 1600930 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium in previous studies (higher amounts, lower molar ratio)
Number of subjects: 57
Study 6143466 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 7.5 micrograms/kg
Number of subjects: 40
Study 6143466 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil 15 micrograms/kg
Number of subjects: 40
Study 6143466 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 1.5 micrograms/kg
Number of subjects: 40
Study 6143466 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 3 micrograms/kg
Number of subjects: 40
Study 6143466 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 31478126 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive myofunctional therapy (PMFT) using an oral device nightly for 1 year
Number of subjects: 57
Study 31478126 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oral device)
Number of subjects: 57
Study 29929533 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen and dexmedetomidine
Number of subjects: 120
Study 29929533 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen and propofol
Number of subjects: 120
Study 29929533 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine and placebo
Number of subjects: 120
Study 29929533 — intervention group
Group type: COMPARATOR
Intervention: Propofol and placebo
Number of subjects: 120
Study 29929533 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study 26178202 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid website
Number of subjects: 101
Study 26178202 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-generated treatment preferences
Number of subjects: 101
Study 26178202 — intervention group
Group type: COMPARATOR
Intervention: Survey first
Number of subjects: 101
Study 25707085 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2 (SB)
Number of subjects: 35
Study 25707085 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambar (AM)
Number of subjects: 35
Study 22344353 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (GI)
Number of subjects: 58
Study 22344353 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypopressive exercises (GII)
Number of subjects: 58
Study 22344353 — intervention group
Group type: COMPARATOR
Intervention: Control group (GIII)
Number of subjects: 58
Study 20717126 — intervention group
Group type: EXPERIMENTAL
Intervention: L-ornithine hydrochloride (0.1 g/kg body mass)
Number of subjects: 14
Study 20717126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 17980769 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsillectomy with Argon Plasma Coagulation (APC)
Number of subjects: 226
Study 17980769 — intervention group
Group type: COMPARATOR
Intervention: Conventional tonsillectomy (cold dissection)
Number of subjects: 226
Study 15842429 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 48
Study 15842429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 12485262 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-ionic radiographic contrast media with different osmolalities
Number of subjects: 0
Study 12485262 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant antithrombotic therapy (platelet aggregation inhibitors and heparins)
Number of subjects: 0
Study 9660243 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral food challenge
Number of subjects: 31
Study 9660243 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy subjects)
Number of subjects: 31
Study 9660243 — intervention group
Group type: COMPARATOR
Intervention: Control (patients with negative food challenge)
Number of subjects: 31
Study 7659391 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortical peel (CP) image analysis using cylindrical transformation of HMPAO SPET data
Number of subjects: 30
Study 7659391 — intervention group
Group type: COMPARATOR
Intervention: Cortical peel (CP) image analysis
Number of subjects: 30
Study 2652199 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative management (tumorectomy and breast irradiation)
Number of subjects: 179
Study 2652199 — intervention group
Group type: COMPARATOR
Intervention: Modified radical mastectomy
Number of subjects: 179
Study 919112 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 47
Study 919112 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 47
Study 30902687 — intervention group
Group type: EXPERIMENTAL
Intervention: B-mode ultrasound (US)
Number of subjects: 111
Study 30902687 — intervention group
Group type: COMPARATOR
Intervention: Manual palpation (MP)
Number of subjects: 111
Study 27926769 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitor therapy
Number of subjects: 76
Study 27926769 — intervention group
Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 76
Study 27926769 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with MF
Number of subjects: 76
Study 26030651 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg/day for 12 months
Number of subjects: 82
Study 26030651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 24002794 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol
Number of subjects: 270
Study 24002794 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 270
Study 20629937 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity endurance exercise for 12 months
Number of subjects: 66
Study 20629937 — intervention group
Group type: COMPARATOR
Intervention: Health education control group
Number of subjects: 66
Study 18848382 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical nephrectomy with complete lymph-node dissection
Number of subjects: 772
Study 18848382 — intervention group
Group type: COMPARATOR
Intervention: Radical nephrectomy alone
Number of subjects: 772
Study 16686769 — intervention group
Group type: EXPERIMENTAL
Intervention: New AH criteria
Number of subjects: 38
Study 16686769 — intervention group
Group type: COMPARATOR
Intervention: Banff criteria
Number of subjects: 38
Study 14600563 — intervention group
Group type: EXPERIMENTAL
Intervention: VG + creatine (VGCr)
Number of subjects: 42
Study 14600563 — intervention group
Group type: EXPERIMENTAL
Intervention: NV + creatine (NVCr)
Number of subjects: 42
Study 14600563 — intervention group
Group type: COMPARATOR
Intervention: VG + placebo (VGPl)
Number of subjects: 42
Study 14600563 — intervention group
Group type: COMPARATOR
Intervention: NV + placebo (NVPl)
Number of subjects: 42
Study 10984252 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) at a dose of 0.6 IU/kg/day (0.2 mg/kg/day)
Number of subjects: 0
Study 10984252 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 0
Study 10984252 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin-like growth factor I (IGF-I) stimulated through the GH axis
Number of subjects: 0
Study 8960082 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine with low dose dipyridamole
Number of subjects: 10
Study 8960082 — intervention group
Group type: COMPARATOR
Intervention: Control (Dobutamine only)
Number of subjects: 10
Study 1493717 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG-IUD
Number of subjects: 209
Study 1493717 — intervention group
Group type: COMPARATOR
Intervention: Nova-T
Number of subjects: 209
Study 3009633 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhesus rotavirus vaccine (MMU 18006)
Number of subjects: 23
Study 31064405 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin 30 mg
Number of subjects: 32
Study 31064405 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin 20 mg
Number of subjects: 32
Study 28332324 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting Early intervention with individual nutrition counseling and nutrition and parenting support groups
Number of subjects: 533
Study 28332324 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard prenatal and pediatric primary care
Number of subjects: 533
Study 25398374 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily for 28 days
Number of subjects: 28
Study 25398374 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 25398374 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib
Number of subjects: 28
Study 22806415 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 60
Study 22806415 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA)
Number of subjects: 60
Study 21710170 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress group (Trier Social Stress Task)
Number of subjects: 87
Study 21710170 — intervention group
Group type: COMPARATOR
Intervention: Non-stress group
Number of subjects: 87
Study 21710170 — intervention group
Group type: EXPERIMENTAL
Intervention: All participants after marijuana cue exposure
Number of subjects: 87
Study 18339466 — intervention group
Group type: EXPERIMENTAL
Intervention: Health services quality improvement intervention
Number of subjects: 19
Study 17120754 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (M)
Number of subjects: 150
Study 17120754 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (F)
Number of subjects: 150
Study 17120754 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (T)
Number of subjects: 150
Study 12627188 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk product containing GABA (FMG)
Number of subjects: 39
Study 12627188 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 11742968 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous breathing trials (SBTs)
Number of subjects: 0
Study 11742968 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-support ventilation (PSV)
Number of subjects: 0
Study 11742968 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 0
Study 11742968 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive positive-pressure ventilation
Number of subjects: 0
Study 10423637 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) therapy
Number of subjects: 0
Study 8273358 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training programs (after patient education)
Number of subjects: 49
Study 3303944 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose piperacillin (4 gm intravenously)
Number of subjects: 116
Study 3303944 — intervention group
Group type: COMPARATOR
Intervention: Multiple-dose piperacillin (three 2 gm doses intravenously 4 hours apart)
Number of subjects: 116
Study 30198779 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy nut (30g/day for 12 weeks)
Number of subjects: 56
Study 30198779 — intervention group
Group type: COMPARATOR
Intervention: Cowpea nut (30g/day for 12 weeks)
Number of subjects: 56
Study 27914512 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 5mg/kg for 2 weeks, then 10mg/kg for the next 2 weeks
Number of subjects: 10
Study 27914512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 24943065 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery for 4 weeks overnight
Number of subjects: 24
Study 24943065 — intervention group
Group type: COMPARATOR
Intervention: Insulin pump therapy for 4 weeks overnight (control)
Number of subjects: 24
Study 23452709 — intervention group
Group type: EXPERIMENTAL
Intervention: Open recovery room (connected to nature)
Number of subjects: 16
Study 23452709 — intervention group
Group type: COMPARATOR
Intervention: Closed recovery room (not connected to nature)
Number of subjects: 16
Study 20890710 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Fatigue Syndrome (CFS) patients during supine rest and LBNP -20 mmHg
Number of subjects: 14
Study 20890710 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Fatigue Syndrome (CFS) patients during LBNP -20 mmHg
Number of subjects: 14
Study 20890710 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects during supine rest and LBNP -20 mmHg
Number of subjects: 14
Study 18692805 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin, 20 mg daily (n = 26)
Number of subjects: 52
Study 18692805 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin, 20 mg daily (n = 26)
Number of subjects: 52
Study 16813773 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional walking (FW) exercise program
Number of subjects: 278
Study 16813773 — intervention group
Group type: EXPERIMENTAL
Intervention: In balance (IB) exercise program
Number of subjects: 278
Study 16813773 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual activities)
Number of subjects: 278
Study 12773973 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extraperitoneal hernia repair (TEP)
Number of subjects: 168
Study 12773973 — intervention group
Group type: COMPARATOR
Intervention: Open mesh technique (Lichtenstein repair)
Number of subjects: 168
Study 10687834 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal replacement therapy (valerate estradiol‐‐2 mg/day for 21 days and cyproterone acetate‐‐1 mg/day for 10 days)
Number of subjects: 41
Study 10687834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 9078545 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO 500 U/kg/wk for 6 weeks
Number of subjects: 14
Study 9078545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 8399013 — intervention group
Group type: COMPARATOR
Intervention: No extra vitamins
Number of subjects: 135
Study 8399013 — intervention group
Group type: COMPARATOR
Intervention: Folic acid supplementation alone
Number of subjects: 135
Study 8399013 — intervention group
Group type: COMPARATOR
Intervention: Folic acid and other vitamin supplementation
Number of subjects: 135
Study 8399013 — intervention group
Group type: COMPARATOR
Intervention: Other vitamin supplementation
Number of subjects: 135
Study 3812449 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease prevalence among persons aged 65+ years
Number of subjects: 817
Study 3812449 — intervention group
Group type: EXPERIMENTAL
Intervention: Alzheimer's disease prevalence among persons aged 80+ years
Number of subjects: 817
Study 3812449 — intervention group
Group type: EXPERIMENTAL
Intervention: Age-adjusted prevalence of Alzheimer's disease in persons aged 65+ years after correction for false negatives
Number of subjects: 817
Study 3812449 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of Alzheimer‐type senile dementia among men
Number of subjects: 817
Study 3812449 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of Alzheimer‐type senile dementia among women
Number of subjects: 817
Study 29783268 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin-primed ovarian stimulation (PPOS)
Number of subjects: 93
Study 29783268 — intervention group
Group type: COMPARATOR
Intervention: Short-term protocol
Number of subjects: 93
Study 27591024 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic (Synergy 1)
Number of subjects: 40
Study 27591024 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Glucidex 29 Premium)
Number of subjects: 40
Study 25037201 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical findings after return to play (RTP)
Number of subjects: 64
Study 22883122 — intervention group
Group type: EXPERIMENTAL
Intervention: Human aspart insulin
Number of subjects: 80
Study 22883122 — intervention group
Group type: COMPARATOR
Intervention: Regular human insulin
Number of subjects: 80